Report Detail

Request for Sample of this report

Other Global Pharmacogenomics Technology (Theranostics & CDx) Supply, Demand and Key Producers, 2026-2032

  • RnM4664032
    • |
  • 19 January, 2026
    • |
  • Global
    • |
  • 97 Pages
    • |
  • GIR
    • |
  • Other

The global Pharmacogenomics Technology (Theranostics & CDx) market size is expected to reach $ 37150 million by 2032, rising at a market growth of 14.4% CAGR during the forecast period (2026-2032).
Pharmacogenomics Technology (Theranostics & CDx) manufacturers include Illumina, Roche and Agilent etc. The top 3 company holds a share of more than 50%. North America takes up the largest sales market, with a share of more than 40%, followed by Europe and China, with the share of about 30% and 10% respectively.
This report studies the global Pharmacogenomics Technology (Theranostics & CDx) demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Pharmacogenomics Technology (Theranostics & CDx), and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Pharmacogenomics Technology (Theranostics & CDx) that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Pharmacogenomics Technology (Theranostics & CDx) total market, 2021-2032, (USD Million)
Global Pharmacogenomics Technology (Theranostics & CDx) total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Pharmacogenomics Technology (Theranostics & CDx) total market, key domestic companies, and share, (USD Million)
Global Pharmacogenomics Technology (Theranostics & CDx) revenue by player, revenue and market share 2021-2026, (USD Million)
Global Pharmacogenomics Technology (Theranostics & CDx) total market by Type, CAGR, 2021-2032, (USD Million)
Global Pharmacogenomics Technology (Theranostics & CDx) total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Pharmacogenomics Technology (Theranostics & CDx) market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Illumina, Roche, Agilent, Abbott, Thermofisher, Qiagen, Guardant Health, MGI Tech Co., Ltd., Amoydx Biology, Genomics, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Pharmacogenomics Technology (Theranostics & CDx) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Pharmacogenomics Technology (Theranostics & CDx) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World
Global Pharmacogenomics Technology (Theranostics & CDx) Market, Segmentation by Type:
Instrument
Reagents and Consumables
Others
Global Pharmacogenomics Technology (Theranostics & CDx) Market, Segmentation by Application:
Tumor
Diabetes
Mental Diseases
Cardiovascular Diseases
Others
Companies Profiled:
Illumina
Roche
Agilent
Abbott
Thermofisher
Qiagen
Guardant Health
MGI Tech Co., Ltd.
Amoydx Biology
Genomics
Key Questions Answered
1. How big is the global Pharmacogenomics Technology (Theranostics & CDx) market?
2. What is the demand of the global Pharmacogenomics Technology (Theranostics & CDx) market?
3. What is the year over year growth of the global Pharmacogenomics Technology (Theranostics & CDx) market?
4. What is the total value of the global Pharmacogenomics Technology (Theranostics & CDx) market?
5. Who are the Major Players in the global Pharmacogenomics Technology (Theranostics & CDx) market?
6. What are the growth factors driving the market demand?


1 Supply Summary

  • 1.1 Pharmacogenomics Technology (Theranostics & CDx) Introduction
  • 1.2 World Pharmacogenomics Technology (Theranostics & CDx) Market Size & Forecast (2021 & 2025 & 2032)
  • 1.3 World Pharmacogenomics Technology (Theranostics & CDx) Total Market by Region (by Headquarter Location)
    • 1.3.1 World Pharmacogenomics Technology (Theranostics & CDx) Market Size by Region (2021-2032), (by Headquarter Location)
    • 1.3.2 United States Based Company Pharmacogenomics Technology (Theranostics & CDx) Revenue (2021-2032)
    • 1.3.3 China Based Company Pharmacogenomics Technology (Theranostics & CDx) Revenue (2021-2032)
    • 1.3.4 Europe Based Company Pharmacogenomics Technology (Theranostics & CDx) Revenue (2021-2032)
    • 1.3.5 Japan Based Company Pharmacogenomics Technology (Theranostics & CDx) Revenue (2021-2032)
    • 1.3.6 South Korea Based Company Pharmacogenomics Technology (Theranostics & CDx) Revenue (2021-2032)
    • 1.3.7 ASEAN Based Company Pharmacogenomics Technology (Theranostics & CDx) Revenue (2021-2032)
    • 1.3.8 India Based Company Pharmacogenomics Technology (Theranostics & CDx) Revenue (2021-2032)
  • 1.4 Market Drivers, Restraints and Trends
    • 1.4.1 Pharmacogenomics Technology (Theranostics & CDx) Market Drivers
    • 1.4.2 Factors Affecting Demand
    • 1.4.3 Major Market Trends

2 Demand Summary

  • 2.1 World Pharmacogenomics Technology (Theranostics & CDx) Consumption Value (2021-2032)
  • 2.2 World Pharmacogenomics Technology (Theranostics & CDx) Consumption Value by Region
    • 2.2.1 World Pharmacogenomics Technology (Theranostics & CDx) Consumption Value by Region (2021-2026)
    • 2.2.2 World Pharmacogenomics Technology (Theranostics & CDx) Consumption Value Forecast by Region (2027-2032)
  • 2.3 United States Pharmacogenomics Technology (Theranostics & CDx) Consumption Value (2021-2032)
  • 2.4 China Pharmacogenomics Technology (Theranostics & CDx) Consumption Value (2021-2032)
  • 2.5 Europe Pharmacogenomics Technology (Theranostics & CDx) Consumption Value (2021-2032)
  • 2.6 Japan Pharmacogenomics Technology (Theranostics & CDx) Consumption Value (2021-2032)
  • 2.7 South Korea Pharmacogenomics Technology (Theranostics & CDx) Consumption Value (2021-2032)
  • 2.8 ASEAN Pharmacogenomics Technology (Theranostics & CDx) Consumption Value (2021-2032)
  • 2.9 India Pharmacogenomics Technology (Theranostics & CDx) Consumption Value (2021-2032)

3 World Pharmacogenomics Technology (Theranostics & CDx) Companies Competitive Analysis

  • 3.1 World Pharmacogenomics Technology (Theranostics & CDx) Revenue by Player (2021-2026)
  • 3.2 Industry Rank and Concentration Rate (CR)
    • 3.2.1 Global Pharmacogenomics Technology (Theranostics & CDx) Industry Rank of Major Players
    • 3.2.2 Global Concentration Ratios (CR4) for Pharmacogenomics Technology (Theranostics & CDx) in 2025
    • 3.2.3 Global Concentration Ratios (CR8) for Pharmacogenomics Technology (Theranostics & CDx) in 2025
  • 3.3 Pharmacogenomics Technology (Theranostics & CDx) Company Evaluation Quadrant
  • 3.4 Pharmacogenomics Technology (Theranostics & CDx) Market: Overall Company Footprint Analysis
    • 3.4.1 Pharmacogenomics Technology (Theranostics & CDx) Market: Region Footprint
    • 3.4.2 Pharmacogenomics Technology (Theranostics & CDx) Market: Company Product Type Footprint
    • 3.4.3 Pharmacogenomics Technology (Theranostics & CDx) Market: Company Product Application Footprint
  • 3.5 Competitive Environment
    • 3.5.1 Historical Structure of the Industry
    • 3.5.2 Barriers of Market Entry
    • 3.5.3 Factors of Competition
  • 3.6 Mergers & Acquisitions Activity

4 United States VS China VS Rest of World (by Headquarter Location)

  • 4.1 United States VS China: Pharmacogenomics Technology (Theranostics & CDx) Revenue Comparison (by Headquarter Location)
    • 4.1.1 United States VS China: Pharmacogenomics Technology (Theranostics & CDx) Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
    • 4.1.2 United States VS China: Pharmacogenomics Technology (Theranostics & CDx) Revenue Market Share Comparison (2021 & 2025 & 2032)
  • 4.2 United States Based Companies VS China Based Companies: Pharmacogenomics Technology (Theranostics & CDx) Consumption Value Comparison
    • 4.2.1 United States VS China: Pharmacogenomics Technology (Theranostics & CDx) Consumption Value Comparison (2021 & 2025 & 2032)
    • 4.2.2 United States VS China: Pharmacogenomics Technology (Theranostics & CDx) Consumption Value Market Share Comparison (2021 & 2025 & 2032)
  • 4.3 United States Based Pharmacogenomics Technology (Theranostics & CDx) Companies and Market Share, 2021-2026
    • 4.3.1 United States Based Pharmacogenomics Technology (Theranostics & CDx) Companies, Headquarters (States, Country)
    • 4.3.2 United States Based Companies Pharmacogenomics Technology (Theranostics & CDx) Revenue, (2021-2026)
  • 4.4 China Based Companies Pharmacogenomics Technology (Theranostics & CDx) Revenue and Market Share, 2021-2026
    • 4.4.1 China Based Pharmacogenomics Technology (Theranostics & CDx) Companies, Company Headquarters (Province, Country)
    • 4.4.2 China Based Companies Pharmacogenomics Technology (Theranostics & CDx) Revenue, (2021-2026)
  • 4.5 Rest of World Based Pharmacogenomics Technology (Theranostics & CDx) Companies and Market Share, 2021-2026
    • 4.5.1 Rest of World Based Pharmacogenomics Technology (Theranostics & CDx) Companies, Headquarters (Province, Country)
    • 4.5.2 Rest of World Based Companies Pharmacogenomics Technology (Theranostics & CDx) Revenue (2021-2026)

5 Market Analysis by Type

  • 5.1 World Pharmacogenomics Technology (Theranostics & CDx) Market Size Overview by Type: 2021 VS 2025 VS 2032
  • 5.2 Segment Introduction by Type
    • 5.2.1 Instrument
    • 5.2.2 Reagents and Consumables
    • 5.2.3 Others
  • 5.3 Market Segment by Type
    • 5.3.1 World Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2021-2026)
    • 5.3.2 World Pharmacogenomics Technology (Theranostics & CDx) Market Size by Type (2027-2032)
    • 5.3.3 World Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Type (2027-2032)

6 Market Analysis by Application

  • 6.1 World Pharmacogenomics Technology (Theranostics & CDx) Market Size Overview by Application: 2021 VS 2025 VS 2032
  • 6.2 Segment Introduction by Application
    • 6.2.1 Tumor
    • 6.2.2 Diabetes
    • 6.2.3 Mental Diseases
    • 6.2.4 Cardiovascular Diseases
    • 6.2.5 Others
  • 6.3 Market Segment by Application
    • 6.3.1 World Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2021-2026)
    • 6.3.2 World Pharmacogenomics Technology (Theranostics & CDx) Market Size by Application (2027-2032)
    • 6.3.3 World Pharmacogenomics Technology (Theranostics & CDx) Market Size Market Share by Application (2021-2032)

7 Company Profiles

  • 7.1 Illumina
    • 7.1.1 Illumina Details
    • 7.1.2 Illumina Major Business
    • 7.1.3 Illumina Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.1.4 Illumina Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.1.5 Illumina Recent Developments/Updates
    • 7.1.6 Illumina Competitive Strengths & Weaknesses
  • 7.2 Roche
    • 7.2.1 Roche Details
    • 7.2.2 Roche Major Business
    • 7.2.3 Roche Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.2.4 Roche Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.2.5 Roche Recent Developments/Updates
    • 7.2.6 Roche Competitive Strengths & Weaknesses
  • 7.3 Agilent
    • 7.3.1 Agilent Details
    • 7.3.2 Agilent Major Business
    • 7.3.3 Agilent Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.3.4 Agilent Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.3.5 Agilent Recent Developments/Updates
    • 7.3.6 Agilent Competitive Strengths & Weaknesses
  • 7.4 Abbott
    • 7.4.1 Abbott Details
    • 7.4.2 Abbott Major Business
    • 7.4.3 Abbott Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.4.4 Abbott Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.4.5 Abbott Recent Developments/Updates
    • 7.4.6 Abbott Competitive Strengths & Weaknesses
  • 7.5 Thermofisher
    • 7.5.1 Thermofisher Details
    • 7.5.2 Thermofisher Major Business
    • 7.5.3 Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.5.4 Thermofisher Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.5.5 Thermofisher Recent Developments/Updates
    • 7.5.6 Thermofisher Competitive Strengths & Weaknesses
  • 7.6 Qiagen
    • 7.6.1 Qiagen Details
    • 7.6.2 Qiagen Major Business
    • 7.6.3 Qiagen Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.6.4 Qiagen Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.6.5 Qiagen Recent Developments/Updates
    • 7.6.6 Qiagen Competitive Strengths & Weaknesses
  • 7.7 Guardant Health
    • 7.7.1 Guardant Health Details
    • 7.7.2 Guardant Health Major Business
    • 7.7.3 Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.7.4 Guardant Health Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.7.5 Guardant Health Recent Developments/Updates
    • 7.7.6 Guardant Health Competitive Strengths & Weaknesses
  • 7.8 MGI Tech Co., Ltd.
    • 7.8.1 MGI Tech Co., Ltd. Details
    • 7.8.2 MGI Tech Co., Ltd. Major Business
    • 7.8.3 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.8.4 MGI Tech Co., Ltd. Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.8.5 MGI Tech Co., Ltd. Recent Developments/Updates
    • 7.8.6 MGI Tech Co., Ltd. Competitive Strengths & Weaknesses
  • 7.9 Amoydx Biology
    • 7.9.1 Amoydx Biology Details
    • 7.9.2 Amoydx Biology Major Business
    • 7.9.3 Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.9.4 Amoydx Biology Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.9.5 Amoydx Biology Recent Developments/Updates
    • 7.9.6 Amoydx Biology Competitive Strengths & Weaknesses
  • 7.10 Genomics
    • 7.10.1 Genomics Details
    • 7.10.2 Genomics Major Business
    • 7.10.3 Genomics Pharmacogenomics Technology (Theranostics & CDx) Product and Services
    • 7.10.4 Genomics Pharmacogenomics Technology (Theranostics & CDx) Revenue, Gross Margin and Market Share (2021-2026)
    • 7.10.5 Genomics Recent Developments/Updates
    • 7.10.6 Genomics Competitive Strengths & Weaknesses

8 Industry Chain Analysis

  • 8.1 Pharmacogenomics Technology (Theranostics & CDx) Industry Chain
  • 8.2 Pharmacogenomics Technology (Theranostics & CDx) Upstream Analysis
  • 8.3 Pharmacogenomics Technology (Theranostics & CDx) Midstream Analysis
  • 8.4 Pharmacogenomics Technology (Theranostics & CDx) Downstream Analysis

9 Research Findings and Conclusion

    10 Appendix

    • 10.1 Methodology
    • 10.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Pharmacogenomics Technology (Theranostics & CDx). Industry analysis & Market Report on Pharmacogenomics Technology (Theranostics & CDx) is a syndicated market report, published as Global Pharmacogenomics Technology (Theranostics & CDx) Supply, Demand and Key Producers, 2026-2032. It is complete Research Study and Industry Analysis of Pharmacogenomics Technology (Theranostics & CDx) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,480.00
    		$6,720.00
    		$8,960.00
    		3,463.04
    		5,194.56
    		6,926.08
    		4,170.88
    		6,256.32
    		8,341.76
    		684,051.20
    		1,026,076.80
    		1,368,102.40
    		378,112.00
    		567,168.00
    		756,224.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo